Tomasz Wirt

Tomasz's academic focus was developing innovative techniques to address the needs of the life sciences sector. He has deep understanding in biotechnology and molecular biology, particularly in nucleic acid applications for molecular diagnostics, imaging, and high-throughput omics research. During his secondment with Nobel Laureate Professor Victor Ambros at the University of Massachusetts Medical School, Tomasz merged his skills in molecular imaging with developmental biology and RNA silencing, further enhancing his knowledge and experience.

He has authored numerous scientific publications and is a co-inventor on two patent applications, highlighting his significant contributions to the field. Beyond academia, Tomasz has played a pivotal role in two Stockholm-based start-ups, coordinating research teams to develop personalised medicine devices and methods.

Before joining Potter Clarkson in 2021, Tomasz led the development of a novel RNA-sequencing-based drug screening platform at SciLifeLab Stockholm.